Supplemental Figure 2

NIAID Data Ecosystem2026-05-02 收录

化疗皮肤毒性

肿瘤支持性护理

数据链接：

https://data.mendeley.com/datasets/kyd5934vyv 数据链接链接失效反馈

官方服务：

资源简介：

Supplemental Figure 2: Fitzpatrick skin type VI, melanonychia and leukonychia (Mee’s lines) in a patient treated with paclitaxel for breast cancer.

创建时间：

2024-08-22

Summary of themes and supporting codes.

肿瘤支持性护理

肌肉减少症

Objectives To 1) explore the experience of patients with lung cancer with low muscle mass or muscle loss during treatment and the ability to cope with treatment, complete self-care, and 2) their recep

NIAID Data Ecosystem30

S3 File -

盆腔放疗后疾病管理

肿瘤支持性护理

To undertake a mixed-methodology implementation study to improve the well-being of men with gastrointestinal late effects following radical radiotherapy for prostate cancer. All men completed a valida

NIAID Data Ecosystem20

Supplemental Figure 5 A-C

化疗皮肤毒性

药物不良反应

Supplemental Figure 5 A-C: Fitzpatrick skin type III, hand foot syndrome from treatment with capecitabine for colon cancer. Onycholysis and subungual hemorrhages in the left first-fourth toenails, wit

NIAID Data Ecosystem10

Rate of skeletal muscle change after chemotherapy and clinical and tumour features in patients with unresectable colorectal cancer.

肿瘤支持性护理

骨骼肌减少症评估

Abbreviations: CEA, carcinoembryonic antigen; EGFR, epidermal growth factor receptor. Values given as mean ± standard deviation or number (%). Rate of skeletal muscle change after chemotherapy and cli

NIAID Data Ecosystem20

Supplementary Material for: Prophylactic Topical Treatment for EGFR Inhibitor-Induced Papulopustular Rash: A Randomized Clinical Trial

肿瘤支持性护理

药物性皮疹管理

Background: The incidence of epidermal growth factor receptor inhibitor (EGFRI)-induced papulopustular rash is 60–85%. Objective: To investigate prophylactic topical treatment for EGFRI-induced rash.

NIAID Data Ecosystem20

Supplemental Figure 2

资源简介：

相关数据集